Compounds > hematoxylin
Page last updated: 2024-08-21

hematoxylin and Malignant Mesothelioma

hematoxylin has been researched along with Malignant Mesothelioma in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Brcic, L; Kern, I; Quehenberger, F; Vlacic, G1
Azimi, V; Banik, G; Chang, YH; Clayburgh, DR; Coussens, LM; Gray, JW; Kawashima, R; Means, C; Sivagnanam, S; Thibault, G; Tsujikawa, T1

Other Studies

2 other study(ies) available for hematoxylin and Malignant Mesothelioma

ArticleYear
Reproducibility of Malignant Pleural Mesothelioma Histopathologic Subtyping.
    Archives of pathology & laboratory medicine, 2018, Volume: 142, Issue:6

    Topics: Eosine Yellowish-(YS); Hematoxylin; Humans; Lung Neoplasms; Mesothelioma; Mesothelioma, Malignant; Observer Variation; Pathologists; Pleural Neoplasms; Prognosis; Reproducibility of Results

2018
Robust Cell Detection and Segmentation for Image Cytometry Reveal Th17 Cell Heterogeneity.
    Cytometry. Part A : the journal of the International Society for Analytical Cytology, 2019, Volume: 95, Issue:4

    Topics: Algorithms; Carcinoma, Pancreatic Ductal; Cell Nucleus; Diagnosis, Differential; Head and Neck Neoplasms; Hematoxylin; Humans; Image Cytometry; Image Interpretation, Computer-Assisted; Immunohistochemistry; Lung Neoplasms; Mesothelioma; Mesothelioma, Malignant; Pancreatic Neoplasms; Pleural Neoplasms; Prognosis; Reproducibility of Results; Sensitivity and Specificity; Single-Cell Analysis; Squamous Cell Carcinoma of Head and Neck; Th17 Cells; Tumor Microenvironment

2019